Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Medical Imaging Techniques and Applications, and Advanced X-ray Imaging Techniques.
Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients
Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline
Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan
Differential associations between regional amyloid PET and Alzheimer’s disease polygenic risk scores
Comparing parametric methods for longitudinal measurement of β‐amyloid pathology with PET in elderly individuals
Quantification of amyloid PET for future clinical use: a state-of-the-art review
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz PET myocardial perfusion imaging
Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load
Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
Automated Quantification of <sup>18</sup>F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
Persistent anterograde amnesia following limbic encephalitis associated with antibodies to the voltage-gated potassium channel complex
Amyloid positron emission tomography with <sup>18</sup>F‐flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease